Does MERCAPTOPURINE Cause Lymphoid tissue hypoplasia? 78 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 78 reports of Lymphoid tissue hypoplasia have been filed in association with MERCAPTOPURINE (Mercaptopurine). This represents 0.7% of all adverse event reports for MERCAPTOPURINE.
78
Reports of Lymphoid tissue hypoplasia with MERCAPTOPURINE
0.7%
of all MERCAPTOPURINE reports
78
Deaths
6
Hospitalizations
How Dangerous Is Lymphoid tissue hypoplasia From MERCAPTOPURINE?
Of the 78 reports, 78 (100.0%) resulted in death, 6 (7.7%) required hospitalization.
Is Lymphoid tissue hypoplasia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MERCAPTOPURINE. However, 78 reports have been filed with the FAERS database.
What Other Side Effects Does MERCAPTOPURINE Cause?
Febrile neutropenia (1,853)
Off label use (893)
Pyrexia (855)
Drug ineffective (721)
Vomiting (488)
Neutropenia (485)
Nausea (418)
Pneumonia (394)
Pancytopenia (392)
Sepsis (389)
What Other Drugs Cause Lymphoid tissue hypoplasia?
CYCLOPHOSPHAMIDE (144)
CYTARABINE (144)
DAUNORUBICIN (144)
DEXAMETHASONE (144)
ETOPOSIDE (144)
FILGRASTIM (144)
CYCLOSPORINE (111)
METHOTREXATE (78)
METHYLPREDNISOLONE (78)
PEGASPARGASE (78)
Which MERCAPTOPURINE Alternatives Have Lower Lymphoid tissue hypoplasia Risk?
MERCAPTOPURINE vs MEROPENEM
MERCAPTOPURINE vs MEROPENEM ANHYDROUS
MERCAPTOPURINE vs MESALAMINE
MERCAPTOPURINE vs MESNA
MERCAPTOPURINE vs METAMIZOLE